Peter J. Tummino
Dr. Tummino received his Ph.D. from the Department of Biological Chemistry, University of Michigan in 1992. After completing a postdoctoral fellowship at Warner-Lambert/Parke-Davis, Dr. Tummino held positions of increasing responsibility at Warner-Lambert/Parke-Davis, AstraZeneca, and Millennium Pharmaceuticals.
He joined GlaxoSmithKline in 2003, was previously Director of the Department of Enzymology and Mechanistic Pharmacology, and is now Head of Biology & Translational Medicine for the Cancer Epigenetics Discovery Performance Unit in Oncology R&D. Dr. Tummino has worked in anti-infective, metabolic disease, and oncology preclinical drug discovery. The focus of his research has been the identification, characterization, and progression of enzyme inhibitors as novel therapeutics.
« Go Back